p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.
about
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@en
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@nl
type
label
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@en
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@nl
prefLabel
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@en
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@nl
P2093
P2860
P1476
p53 Nongenotoxic Activation an ...... ion for Neuroblastoma Therapy.
@en
P2093
Anna Lakoma
Eveline Barbieri
Jan J Molenaar
Jason M Shohet
Kathleen A Scorsone
Kevin Aviles-Padilla
Linda Schild
Myrthala Moreno-Smith
Rana Nikzad
P2860
P304
P356
10.1158/1078-0432.CCR-17-0668
P407
P577
2017-08-18T00:00:00Z